Hallmarks of neurodegenerative disease: A systems pharmacology perspective
Abstract Age‐related central neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, are a rising public health concern and have been plagued by repeated drug development failures. The complex nature and poor mechanistic understanding of the etiology of neurodegenerative d...
Main Authors: | Peter Bloomingdale, Tatiana Karelina, Vidya Ramakrishnan, Suruchi Bakshi, Florence Véronneau‐Veilleux, Matthew Moye, Kazutaka Sekiguchi, Guy Meno‐Tetang, Aparna Mohan, R. Maithreye, Veena A. Thomas, Frank Gibbons, Antonio Cabal, Jean‐Marie Bouteiller, Hugo Geerts |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-11-01
|
Series: | CPT: Pharmacometrics & Systems Pharmacology |
Online Access: | https://doi.org/10.1002/psp4.12852 |
Similar Items
-
GBA1 inactivation in oligodendrocytes affects myelination and induces neurodegenerative hallmarks and lipid dyshomeostasis in mice
by: Ilaria Gregorio, et al.
Published: (2024-03-01) -
Neurophysiological Hallmarks of Neurodegenerative Cognitive Decline: The Study of Brain Connectivity as A Biomarker of Early Dementia
by: Paolo Maria Rossini, et al.
Published: (2020-04-01) -
Quantitative systems pharmacology in neuroscience: Novel methodologies and technologies
by: Peter Bloomingdale, et al.
Published: (2021-05-01) -
Phasic Dopamine Changes and Hebbian Mechanisms during Probabilistic Reversal Learning in Striatal Circuits: A Computational Study
by: Miriam Schirru, et al.
Published: (2022-03-01) -
The hallmarks of autism
by: Bernard J. Crespi
Published: (2022-08-01)